Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Affimed Q4 EPS $(1.50) Beats $(1.67) Estimate, Sales $444.55K Miss $1.70M Estimate

Author: Benzinga Newsdesk | March 28, 2024 08:25am
Affimed (NASDAQ:AFMD) reported quarterly losses of $(1.50) per share which beat the analyst consensus estimate of $(1.67) by 10.18 percent. This is a 31.82 percent increase over losses of $(2.20) per share from the same period last year. The company reported quarterly sales of $444.55 thousand which missed the analyst consensus estimate of $1.70 million by 73.85 percent. This is a 96.10 percent decrease over sales of $11.39 million the same period last year.

Posted In: AFMD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist